Cover Image
市場調查報告書

過敏診斷的全球市場 ∼2021年:各產品 (檢測套件、免疫檢測分析設備、光度計、消耗品、服務)、過敏原、檢驗方法、終端用戶的預測

Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 321266
出版日期 內容資訊 英文 193 Pages
訂單完成後即時交付
價格
Back to Top
過敏診斷的全球市場 ∼2021年:各產品 (檢測套件、免疫檢測分析設備、光度計、消耗品、服務)、過敏原、檢驗方法、終端用戶的預測 Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021
出版日期: 2016年06月13日 內容資訊: 英文 193 Pages
簡介

全球過敏診斷相關的市場規模,預計2016年達29億8000萬美元,2021年達53億4000萬美元,以12.4%的年複合成長率 (CAGR) 擴大。市場成長的主要推動因素,是過敏疾病患者的增加,加上環境污染的擴大,醫療費的增加,美國的醫療保險制度改革等。在各產品中,預計檢驗用試劑組今後將急速成長。

本報告提供過敏診斷的全球市場為焦點,過敏原 (過敏誘發物質),產品與服務,檢驗方法,終端用戶,地區等各分類的變化預測,市場現狀,發展的影響要素,競爭環境,主要企業等最新的調查、分析資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 應特別記載考察點

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動要素
      • 過敏疾病的發病率高和經濟負擔重
      • 環境污染的擴大
      • 醫療費擴大
      • 改善美國的醫療保險獲取
    • 阻礙因素
      • 對醫療設備的嚴格法規
      • 過敏疾病的認識度低
      • 高額的設備投資的必要性
      • 市場集中度高:對新加入企業的市場障礙
    • 機會
      • 亞洲市場急速成長的機會
    • 趨勢
      • 過敏診斷設備的響應時間的快速與處理能力高
      • 檢驗試劑出租契約的登場
      • 迅速的判斷
      • 高的處理能力

第6章 產業趨勢

  • 簡介
  • 市場指標
    • 過敏疾病的發病率高和經濟負擔重
  • 產業趨勢
    • 反應時間的快速與處理能力高
  • 波特的五力分析
  • 價值鏈分析
  • 主要的影響
  • 策略性基準

第7章 過敏診斷市場:各產品

  • 簡介
  • 診斷套件
  • 診斷設備
    • 免疫檢測分析設備
    • 光度計
    • ELISA (酵素結合免疫吸附法) 分析設備
    • 其他
  • 服務

第8章 過敏診斷市場:各過敏原

  • 簡介
  • 吸入過敏原
  • 食品過敏原
  • 藥物過敏原
  • 其他過敏原

第9章 過敏診斷市場:檢驗方法

  • 簡介
  • 生體內 (in vivo) 檢驗
  • 體外 (in vitro) 檢驗

第10章 過敏診斷市場:各終端用戶

  • 簡介
  • 診斷測試所
  • 醫院
  • 學術研究機關
  • 其他

第11章 過敏診斷市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲各國
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 其他亞洲各國
  • 其他地區 (ROW)
    • 南美、中美、加勒比海地區
    • 太平洋、大洋洲
    • 非洲

第12章 競爭環境

  • 簡介
  • 策略概要
  • 市場佔有率分析
  • 競爭情形及趨勢
    • 新產品銷售
    • 產業擴張
    • 協定,聯盟、合作
    • 企業收購
    • 其他的發展

第13章 企業簡介 (概要、產品與服務、策略&分析&考察、近幾年趨勢、MnM的見解)

  • 簡介
  • BIOMERIEUX
  • DANAHER CORPORATION
  • HITACHI CHEMICAL DIAGNOSTICS, INC.
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC, INC.
  • HOB BIOTECH GROUP
  • HYCOR BIOMEDICAL
  • INCOLN DIAGNOSTICS, INC.
  • OMEGA DIAGNOSTICS GROUP PLC
  • STALLERGENES GREER

第14章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 2955

The allergy diagnostics market is expected to reach USD 5.34 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 12.4%. The global allergy diagnostics market is segmented based on product, allergen, test, end user, and region. The assay kits segment is expected to register the highest growth rate in the allergy diagnostics market, by product, during the forecast period. The high growth in this segment is attributed to the increase in number of allergens and increasing healthcare expenditure worldwide.

Based on end users, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals, academic research institutes, and other end users. The diagnostic laboratories segment is expected to account for the largest share of the market in 2016. Increasing prevalence of allergic diseases and the need for developing new therapies will drive the growth of this market.

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising aging population and benefits for youth in health insurance.

The major factors contributing to the growth of the allergy diagnostics market include increasing incidences of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and increase in access to medical insurance in the U.S. On the other hand, stringent regulatory policies for validation of medical devices and the highly consolidated market which creates an obstacle for entry of small players are the major factors restraining the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the allergy diagnostics market.

The major players in the allergy diagnostics market include bioMerieux SA (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics, Inc. (Japan), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Stallergenes Greer (France), HOB Biotech Group Co., Ltd (China), HYCOR Biomedical (U.S.), Lincoln Diagnostics, Inc. (U.S.), and Omega Diagnostics Group PLC (U.K.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market. The report analyses the allergy diagnostics market by product, allergen, test, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various allergy diagnostics market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. ALLERGY DIAGNOSTICS MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. High Incidences and Large Economic Burden of Allergic Diseases
      • 5.3.1.2. Rising Environmental Pollution
      • 5.3.1.3. Increasing Healthcare Expenditure
      • 5.3.1.4. Increase in Access to Medical Insurance in the U.S.
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Stringent Regulations for Medical Devices
      • 5.3.2.2. Lack of Awareness about Allergic Diseases
      • 5.3.2.3. High Capital Requirements
      • 5.3.2.4. High Degree of Consolidation Acts as an Entry Barrier for New Entrants
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Asian Market Presents High-Growth Opportunities
    • 5.3.4. TRENDS
      • 5.3.4.1. Quick Turnaround Times and High Throughput of Allergy Diagnostic Systems
      • 5.3.4.2. Rise in Reagent Rental Agreements

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. MARKET INDICATORS
    • 6.2.1. HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. QUICK TURNAROUND TIMES AND HIGH THROUGHPUT
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT FROM SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF BUYERS
    • 6.4.4. BARGAINING POWER OF SUPPLIERS
    • 6.4.5. INTENSITY OF RIVALRY
  • 6.5. VALUE CHAIN ANALYSIS
  • 6.6. KEY INFLUENCERS
  • 6.7. STRATEGIC BENCHMARKING

7. ALLERGY DIAGNOSTICS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. ASSAY KITS
  • 7.3. INSTRUMENTS
    • 7.3.1. IMMUNOASSAY ANALYZERS
    • 7.3.2. LUMINOMETERS
    • 7.3.3. ELISA ANALYZERS
    • 7.3.4. OTHER INSTRUMENTS
  • 7.4. SERVICES

8. ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS

  • 8.1. INTRODUCTION
  • 8.2. INHALED ALLERGENS
  • 8.3. FOOD ALLERGENS
  • 8.4. DRUG ALLERGENS
  • 8.5. OTHER ALLERGENS

9. ALLERGY DIAGNOSTICS MARKET, BY TEST

  • 9.1. INTRODUCTION
  • 9.2. IN VIVO TESTS
  • 9.3. IN VITRO TESTS

10. ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. DIAGNOSTIC LABORATORIES
  • 10.3. HOSPITALS
  • 10.4. ACADEMIC RESEARCH INSTITUTES
  • 10.5. OTHER END USERS

11. ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA
    • 11.4.1. CHINA
    • 11.4.2. JAPAN
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA (ROA)
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN
    • 11.5.2. PACIFIC AND OCEANIA
    • 11.5.3. AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. STRATEGIC OVERVIEW
  • 12.3. MARKET SHARE ANALYSIS
  • 12.4. COMPETITIVE SITUATION AND TRENDS
    • 12.4.1. NEW PRODUCT LAUNCHES
    • 12.4.2. EXPANSIONS
    • 12.4.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.4.4. ACQUISITIONS
    • 12.4.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. BIOMERIEUX
  • 13.3. DANAHER CORPORATION
  • 13.4. HITACHI CHEMICAL DIAGNOSTICS, INC.
  • 13.5. SIEMENS AG
  • 13.6. THERMO FISHER SCIENTIFIC, INC.
  • 13.7. HOB BIOTECH GROUP
  • 13.8. HYCOR BIOMEDICAL
  • 13.9. LINCOLN DIAGNOSTICS, INC.
  • 13.10. OMEGA DIAGNOSTICS GROUP PLC
  • 13.11. STALLERGENES GREER

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: THE ECONOMIC BURDEN OF ALLERGIES
  • TABLE 2: INCREASING HEALTHCARE EXPENDITURE IS AN IMPORTANT DRIVER FOR THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 3: STRINGENT REGULATORY POLICIES FOR VALIDATION OF DEVICES PRODUCTS TO RESTRICT MARKET GROWTH
  • TABLE 4: ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 5: HIGH-THROUGHPUT TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 6: ECONOMIC BURDEN OF ALLERGIES BOOSTING THE GROWTH OF ALLERGY DIAGNOSTICS MARKET
  • TABLE 7: MARKET DEVELOPMENTS BETWEEN 2012 AND 2016
  • TABLE 8: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 9: ALLERGY DIAGNOSTICS ASSAY KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ALLERGY DIAGNOSTICS IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: ALLERGY DIAGNOSTICS LUMINOMETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: ALLERGY DIAGNOSTICS ELISA ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: ALLERGY DIAGNOSTICS OTHER INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: ALLERGY DIAGNOSTICS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGENS, 2014-2021 (USD MILLION)
  • TABLE 18: INHALED ALLERGEN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: ALLERGY DIAGNOSTICS MARKET SIZE FOR INHALED ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: FOOD ALLERGEN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 21: ALLERGY DIAGNOSTICS MARKET SIZE FOR FOOD ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: ALLERGY DIAGNOSIS MARKET SIZE FOR DRUG ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: ALLERGY DIAGNOSIS MARKET SIZE FOR OTHER ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 25: IN VIVO ALLERGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: IN VITRO ALLERGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 28: ALLERGY DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: ALLERGY DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ALLERGY DIAGNOSTICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: ALLERGY DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 40: CANADA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 41: CANADA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 47: GERMANY: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 48: GERMANY: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 49: U.K.: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: U.K.: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 51: FRANCE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 52: FRANCE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 53: ITALY: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: ITALY: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: SPAIN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: SPAIN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: ROE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 58: ROE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 62: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: CHINA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 66: JAPAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: JAPAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: INDIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: INDIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: ROA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 71: ROA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 77: SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 80: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: AFRICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: AFRICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: MARKET DEVELOPMENTS BETWEEN JANUARY 2012 AND MARCH 2016
  • TABLE 84: NEW PRODUCT LAUNCHES, 2012-2016
  • TABLE 85: EXPANSIONS, 2012-2016
  • TABLE 86: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2016
  • TABLE 87: ACQUISITIONS, 2012-2016
  • TABLE 88: OTHER DEVELOPMENTS, 2012-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL ALLERGY DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: ALLERGY DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE OF ALLERGEN, 2016 VS 2021 (USD MILLION)
  • FIGURE 9: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE OF TESTS, 2016 VS 2021 (USD MILLION)
  • FIGURE 10: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS 2021 (USD MILLION)
  • FIGURE 11: GLOBAL ALLERGY DIAGNOSTICS MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 12: GLOBAL ALLERGY DIAGNOSTICS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: DIAGNOSTIC LABORATORIES SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 14: ASIA TO WTINESS THE FASTEST GROWTH IN THE FORECAST PERIOD (2016-2021)
  • FIGURE 15: ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 16: ALLERGY DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 17: HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES WILL DRIVE THE ALLERGY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: RISING ENVIRONMENTAL POLLUTION ACROSS THE GLOBE (2010 VS. 2011)
  • FIGURE 19: INCREASING HEALTHCARE EXPENDITURE IS A CRUCIAL FACTOR DRIVING THE GROWTH OF THE ALLERGY DIAGNOSTICS MARKET
  • FIGURE 20: GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT IN AMERICAS AND EUROPE
  • FIGURE 21: PORTER'S FIVE FORCES ANALYSIS (2016): PRESENCE OF LARGE NUMBER OF MANUFACTURING FIRMS INCREASES COMPETITION
  • FIGURE 22: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
  • FIGURE 23: DIRECT DISTRIBUTION-STRATEGY PREFERRED BY PROMINENT COMPANIES
  • FIGURE 24: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT
  • FIGURE 25: ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2016
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS ASSAY KITS MARKET IN 2016
  • FIGURE 27: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY TYPE, 2016 (USD MILLION)
  • FIGURE 28: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ALLERGY DIAGNOSTICS INSTRUMENTS MARKET IN 2016
  • FIGURE 29: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IMMUNOASSAY ANALYZERS MARKET IN 2016
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE LUMINOMETERS MARKET IN 2016
  • FIGURE 31: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ELISA ANALYZERS MARKET IN 2016
  • FIGURE 32: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER INSTRUMENTS MARKET IN 2016
  • FIGURE 33: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ALLERGY DIAGNOSTICS SERVICES MARKET IN 2016
  • FIGURE 34: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY ALLERGENS
  • FIGURE 35: INHALED ALLERGENS TO BE THE LARGEST ALLERGEN SEGMENT IN 2016
  • FIGURE 36: ANIMAL ORIGIN TO BE THE LARGEST TYPE SEGMENT IN INHALED ALLERGEN MARKET IN 2016
  • FIGURE 37: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE INHALED ALLERGENS SEGMENT IN 2016
  • FIGURE 38: PLANT ORIGIN TO BE THE LARGEST TYPE SEGMENT IN FOOD ALLERGEN MARKET IN 2016
  • FIGURE 39: NORTH AMERICA TO DOMINATE THE MARKET FOR FOOD ALLERGENS IN 2016
  • FIGURE 40: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF DRUG ALLERGENS SEGMENT IN 2016
  • FIGURE 41: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSIS MARKET FOR OTHER ALLERGENS IN 2016
  • FIGURE 42: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY TEST
  • FIGURE 43: IN VIVO TESTS TO FORM THE LARGEST TEST SEGMENT IN 2016
  • FIGURE 44: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IN VIVO ALLERGY TESTING MARKET IN 2016
  • FIGURE 45: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IN VITRO ALLERGY TESTING MARKET IN 2016
  • FIGURE 46: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY END USER
  • FIGURE 47: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 (USD MILLION)
  • FIGURE 48: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES IN 2016
  • FIGURE 49: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR HOSPITALS BETWEEN 2016 AND 2021
  • FIGURE 50: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2016 AND 2021
  • FIGURE 51: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS BETWEEN 2016 AND 2021
  • FIGURE 52: ALLERGY DIAGNOSTICS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2016-2021
  • FIGURE 53: ALLERGY DIAGNOSTICS MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE (2016 TO 2021)
  • FIGURE 54: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 55: U.S. TO DOMINATE THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET
  • FIGURE 56: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 57: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 58: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY ALLERGEN TYPE, IN NORTH AMERICA (2016)
  • FIGURE 59: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY END USER, IN NORTH AMERICA
  • FIGURE 60: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 61: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN THE U.S.
  • FIGURE 62: GERMANY IS ESTIMATED TO DOMINATE THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 63: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 64: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 65: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN EUROPE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 66: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN EUROPE
  • FIGURE 67: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE GERMAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 68: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN GERMANY
  • FIGURE 69: ASIA: MARKET SNAPSHOT
  • FIGURE 70: CHINA IS ESTIMATED TO DOMINATE THE ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 71: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 72: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 73: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 74: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN ASIA
  • FIGURE 75: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN CHINESE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 76: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN CHINA
  • FIGURE 77: SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN IS ESTIMATED TO DOMINATE THE ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 78: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 79: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 80: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 81: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN ROW
  • FIGURE 82: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 83: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN
  • FIGURE 84: NEW PRODUCT LAUNCH AND EXPANSIONS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET
  • FIGURE 85: ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 86: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 87: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 88: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 89: COMPANY SNAPSHOT: HITACHI CHEMICAL DIAGNOSTICS, INC.
  • FIGURE 90: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 91: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 92: COMPANY SNAPSHOT: OMEGA DIAGNOSTICS GROUP PLC
  • FIGURE 93: COMPANY SNAPSHOT: STALLERGENES GREER
Back to Top